在老年人中发生的阳性药物错误报告给毒药中心网络
Hayley T Gartner1, Reeves E Simmons1, Herbert Z Wan1
1Florida/USVI Poison Information Center Jacksonville, University of Florida Health Jacksonville, Jacksonville, Florida, USA.
概括
老年人中催化剂药物错误很常见,特别是在药物给药时和涉及心血管药物时. 许多错误会造成伤害,急诊室 (ED) 事件带来更高的风险,需要有针对性的干预.
科学领域:
- 老年医学 老年医学
- 患者安全 患者安全
- 药理学 药理学是指药理学的学科.
背景情况:
- 催化剂药物错误对老年人来说是一个重要的,可以预防的伤害.
- 这些错误的全部范围,类型和后果仍然不够理解.
- 本研究涉及老年患者的医疗保健相关药物错误的特征,包括紧急和医院前设置.
研究的目的:
- 描述65岁及以上的成年人中与医疗保健相关的有机药物错误.
- 为了确定这些药物错误的设置,类型和结果.
- 为了告知有针对性的干预措施,以防止对这个脆弱人群的伤害.
主要方法:
- 对65岁以上患者进行回顾性队列研究,报告给毒药中心网络 (2020-2025) 的阳性药物暴露.
- 从电子健康记录中提取的数据,并检查医疗保健相关的药物错误.
- 使用国家毒素数据系统 (NPDS) 和国家药物错误报告和预防协调委员会 (NCC MERP) 尺度评估错误严重程度;临床效应,药物和治疗方法被描述性地分析.
主要成果:
- 182个病例符合纳入标准,大多数错误发生在护理机构 (32%),非重症监护单位 (14%) 或急诊室 (12%).
- 心血管类药物最常涉及 (32%),其中注射错误 (77%),包括错误的患者 (24%) 或错误的剂量 (20%) 是主要原因.
- 超过一半的错误被归类为NCC MERP类别E或更高的错误,表明患者受到伤害.
结论:
- 老年人中催化剂药物错误在各种护理环境中普遍存在,经常需要急诊室 (ED) 管理.
- 虽然许多错误会造成轻微的伤害,但很大一部分会导致严重的后果,基于ED的错误表明风险更高.
- 研究结果强调,需要在药物管理过程中采取有针对性的干预措施,特别是对于心血管药物,以保护老年人.
相关概念视频
Pharmaceutical Poisoning: Potential Scenarios
37
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
37
Drug Dosing: Geriatric Patients
319
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
319
Drug Toxicity: Risk factors
55
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
55
Anticholinesterase Agents: Poisoning and Treatment
1.8K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.8K
Pharmacodynamics in Geriatric Patients: Effects of Age
278
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
278
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
267
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
267


